$71.85
1.71% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US36266G1076
Symbol
GEHC
Sector

GE HealthCare Technologies Stock price

$71.85
+11.37 18.80% 1M
-13.05 15.37% 6M
-6.33 8.10% YTD
-9.90 12.11% 1Y
+11.85 19.75% 3Y
+11.85 19.75% 5Y
+11.85 19.75% 10Y
Nasdaq, Closing price Tue, May 20 2025
-1.25 1.71%
ISIN
US36266G1076
Symbol
GEHC
Sector

Key metrics

Market capitalization $32.90b
Enterprise Value $39.84b
P/E (TTM) P/E ratio 15.11
EV/FCF (TTM) EV/FCF 29.00
EV/Sales (TTM) EV/Sales 2.01
P/S ratio (TTM) P/S ratio 1.66
P/B ratio (TTM) P/B ratio 3.58
Dividend yield 0.17%
Last dividend (FY24) $0.12
Revenue growth (TTM) Revenue growth 1.55%
Revenue (TTM) Revenue $19.80b
EBIT (operating result TTM) EBIT $2.95b
Free Cash Flow (TTM) Free Cash Flow $1.37b
Cash position $2.47b
EPS (TTM) EPS $4.76
P/E forward 17.42
P/S forward 1.62
EV/Sales forward 1.96
Short interest 1.92%
Show more

Create a Free Account to create an GE HealthCare Technologies alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

GE HealthCare Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a GE HealthCare Technologies forecast:

15x Buy
71%
6x Hold
29%

Analyst Opinions

21 Analysts have issued a GE HealthCare Technologies forecast:

Buy
71%
Hold
29%

Financial data from GE HealthCare Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
19,798 19,798
2% 2%
100%
- Direct Costs 11,567 11,567
0% 0%
58%
8,231 8,231
4% 4%
42%
- Selling and Administrative Expenses 3,386 3,386
2% 2%
17%
- Research and Development Expense 1,331 1,331
6% 6%
7%
3,514 3,514
9% 9%
18%
- Depreciation and Amortization 569 569
5% 5%
3%
EBIT (Operating Income) EBIT 2,945 2,945
13% 13%
15%
Net Profit 2,184 2,184
39% 39%
11%

In millions USD.

Don't miss a Thing! We will send you all news about GE HealthCare Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GE HealthCare Technologies Stock News

Neutral
Business Wire
6 days ago
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and changes in the distribut...
Neutral
Business Wire
8 days ago
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company's Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric p...
Neutral
Business Wire
8 days ago
CHICAGO & SAN RAMON, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring tec...
More GE HealthCare Technologies News

Company Profile

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Head office United States
CEO Peter Arduini
Employees 53,000
Founded 2022
Website www.gehealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today